Bile duct cancer, Biliary tree cancers, Gallbladder cancer
Results
Phase 1
This trial looked at a drug called selumetinib with chemotherapy for cancer of the bile duct or gallbladder (the biliary tract). Cancer Research UK supported this trial.
Recruitment start: 24 February 2012
Recruitment end: 4 January 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr John Bridgewater
AstraZeneca
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
University College London (UCL)
This is Cancer Research UK trial number CRUKE/10/036
Last reviewed: 08 Jun 2016
CRUK internal database number: 6196